ALFA Finder India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold Telegram alerts alfafinder.com →
Saturday, 14 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Investor Presentation

Nureca Investor Presentation: Key Takeaways

Nureca Limited reported its strongest performance in 16 quarters for Q1 FY'27, achieving a revenue of ₹40.3 Cr and shifting to a profitable trajectory with a 10.5% PBT margin.

Highlights
Revenue growth18% YoY
MarginsOperating margin improved to 8.7% from -1.8% YoY.
Demand visibilityStrong; market projected to reach ₹5,203 Cr by 2030.
Management confidenceHigh; citing operational turnaround and sustainable value creation.

Growth

Revenue grew 14% QoQ and 18% YoY; PAT increased 244% YoY to ₹3.1 Cr.

Outlook

Focus on manufacturing expansion in Punjab for import substitution; scaling AI-powered Dr Trust 360 ecosystem.

Risks

Company faces competitive pressures in the consumer healthcare market and reliance on e-commerce (87.6% sales).

Source

Investor Presentation filed with NSE, NSE: NURECA. Summary written with AI assistance from the document.

Read the document ↗

Nureca Ltd: key numbers

Share price
₹306.55
Market cap
₹306.6 Cr
Revenue (annual)
₹147.0 Cr
Net profit (annual)
₹2.08 Cr
P/E (TTM)
64.4×Sector 55.1×
Promoter holding
70.68%+2.59% QoQ
FII holding
0.22%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Nureca Ltd

All →
13:54 IST BSE
Financial Results

Nureca Q2 FY27 Results: Net Profit ₹4.1 Cr, Up 13.9% YoY

Nureca Ltd reported revenue from operations of ₹58.5 Cr (+55.2% YoY) and net profit of ₹4.1 Cr (+13.9% YoY) for Q2 FY27.

Key figure
Net profit ₹4.1 Cr · +13.9% YoY